T he fear-avoidance model of musculoskeletal pain (FAM) is a current model used to explain the development and maintenance of chronic low back pain (LBP) . 1 The FAM proposes that pain perception is primarily influenced by pain-related fear and pain catastrophizing. [1] [2] [3] These psychological factors interact to determine an individual's initial behavioral response to acute pain. Low levels of pain-related fear and pain catastrophizing are associated with a confrontation behavioral response, which is believed to be a precursor to resuming normal activities. [1] [2] [3] In contrast, high levels of pain-related fear and pain catastrophizing are associated with an avoidance behavioral response, which is believed to be a precursor to experiencing chronic disability. [1] [2] [3] Evidence supporting the FAM can be found in prospective clinical studies of pain-related fear. Several longitudinal studies 4 -9 suggested that elevated measures of pain-related fear were predictive of poor LBP outcomes. Evidence supporting the FAM also can be found in studies incorporating treatment strategies to reduce pain-related fear. Effective LBP treatment strategies consistent with the FAM have been reported in the literature, and these interventions include patient education, 10, 11 graded exercise, 12,13 and graded exposure. 14 -17 Collectively, the previously cited studies provide an empirical foundation for the FAM and suggest that the model may have clinical relevance for patients with LBP. 1 Whether measurement of painrelated fear needs to be general or specific to an activity is an unresolved issue related to the FAM. 1 Validated questionnaires assess beliefs related to the perceived harm and threat of experiencing LBP or performing physical activity while in pain. 18, 19 Examples of specific activities are not provided when patients respond to these questionnaires, 18, 19 limiting their use in developing treatment programs that incorporate graded, hierarchical exposure to specific fearful activities (ie, graded exposure). It has been hypothesized that graded exposure is more effective than quota-driven approaches to increasing general activity levels (ie, graded activity or exercise). 1, 14, 20, 21 Measurement limitations may hamper future clinical investigation of the FAM because testing graded exposure hypotheses in physical therapy settings require reliable and valid instruments to assess fear of specific activities.
Therefore, the purpose of this study was to describe the psychometric properties of a novel self-report measure for fear of activities for patients with LBP. The Fear of Daily Activities Questionnaire (FDAQ) recently was developed to guide physical therapy supplemented with graded exposure in a clinical trial. 20 In the current study, we investigated test-retest reliability, internal consistency, construct validity, concurrent validity, predictive validity, and responsiveness for the FDAQ. We hypothesized that the FDAQ would demonstrate adequate psychometric properties, suggesting potential utility for patients with LBP.
Method Overview
All participants provided informed consent before study participation was confirmed. Psychometric properties of the FDAQ have not been reported previously, and 2 cohorts were recruited for this study. The first cohort consisted of patients with chronic LBP. These participants were used primarily for analyses to investigate the reliability of FDAQ scores because they would be clinically stable during the 48-hour testretest period. The second cohort consisted of participants with acute or subacute LBP participating in a clinical trial. 20 These participants were expected to have changes in their clinical status during the 4-week follow-up and were used in analyses to investigate the validity of FDAQ scores. The clinical trial utilized the FDAQ to measure specific fear of activities for implementing graded exposure, but the FDAQ was not used as an outcome measure.
Participants
The inclusion and exclusion criteria for the reliability and validity cohorts were based on guidelines from the Quebec Task Force on Spinal Disorders. 22 For the purposes of this study, acute and subacute LBP were operationally defined as reporting current symptoms for 1 to 24 weeks and chronic LBP was defined as reporting current symptoms for greater than 24 weeks.
Reliability cohort. A sample of convenience was recruited from patients seeking treatment for LBP at University of Florida-affiliated outpatient clinics. Inclusion criteria were being between 15 and 60 years of age and having chronic LBP with or without radiating symptoms. Patients had to have the ability to read and speak English because questionnaires were used. Exclusion criteria were having acute or subacute LBP, signs of nerve root compression, 18 The PCS is a 13-item scale that assesses the degree of catastrophic cognitions a patient reports due to LBP. The PCS has a total range of scores of 0 to 52, and higher scores are associated with higher amounts of pain catastrophizing.
Physical impairment. The previously described Physical Impairment Scale (PIS) 23 was used to quantify physical impairment due to LBP. The PIS consists of 7 different examination procedures performed by the patient, and performance for each procedure is scored as a negative (0) or positive (1) for presence of impairment. The PIS has a total range of scores of 0 to 7, and higher scores indicate higher levels of physical impairment due to LBP.
Pain and disability. Participants rated their pain intensity using an NRS ranging from 0 ("no pain") to 10 ("worst pain imaginable"). 24 They rated pain intensity over 3 conditions: the present pain intensity, the worst pain intensity over the past 24 hours, and the best pain intensity over the past 24 hours. These 3 ratings were summed and divided by 3 (arithmetic mean) for use in data analyses. 25 Disability was assessed with the Oswestry Disability Questionnaire (ODQ), which has been recommended as an appropriate outcome measure for self-report of disability. 26, 27 The ODQ has 10 items that assess how LBP affects common daily activities (eg, sitting, standing, lifting). The ODQ has a range of scores of 0 ("no disability due to back pain") to 100 ("completely disabled due to back pain"), so higher scores indicate higher disability from LBP.
Procedure Reliability cohort. Participants who met the eligibility criteria for the reliability cohort provided informed consent and completed the FDAQ, NRS for pain intensity, and ODQ during a routine appointment
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for outpatient physical therapy. They then were given a self-addressed, stamped envelope with instructions to complete the FDAQ again 48 hours later. They were instructed to complete the FDAQ, provide the date of completion on the form, and mail it to the authors.
Validity cohort. Participants who met the eligibility criteria for the validity cohort provided informed consent and completed the FDAQ, along with the FABQ, PCS, NRS for pain intensity, and ODQ. A physical therapist who was masked to group assignment administered the PIS at baseline. The participants then were treated for 4 weeks by licensed physical therapists according to their random assignment of physical therapy alone, physical therapy supplemented with graded exercise, or physical therapy supplemented with graded exposure. The participants were reassessed on the same measures by a blinded evaluator 4 weeks after randomization. The primary analysis of the trial indicated no differences in 4-week outcomes for any of the previously validated measures used in this study. Therefore, participants were analyzed as a single cohort for the purpose of this study, instead of in randomly assigned treatment groups.
Data Analysis Reliability cohort. Descriptive analyses were generated and reported in the appropriate metric for continuous and categorical variables. Reliability analyses included analysis of internal consistency (Cronbach alpha) for individual FDAQ items and analysis of test-retest reliability (intraclass correlation coefficient [ICC] [2,1]) for the total FDAQ score. These results were reported with appropriate coefficient and 95% confidence interval (CI). From these data, the standard error of measurement (SEM) was calculated using a previously described method (standard deviation ϫ ͌(1 -test-retest reliability coefficient). 28 -30 The minimal detectable change (MDC) also was calculated using a previously described method (1.96ϫSEM). 31
Validity cohort. Descriptive analyses were generated and reported in the appropriate metric for continuous and categorical variables. Construct validity was assessed with factor analysis (principal component analysis, varimax rotation with Kaiser normalization) at baseline and 4 weeks. Concurrent validity was assessed by reporting correlations (Pearson r) of the FDAQ with the FABQ, PCS, PIS, NRS for pain intensity, and ODQ at baseline and 4 weeks.
Concurrent validity was assessed further by separate multiple regression models for baseline and 4-week measures. These models tested FDAQ contributions to disability or physical impairment after controlling for pain intensity and commonly implemented measures of FAM variables. The independent variables for these regression analyses were the FDAQ, NRS for pain intensity, FABQ-PA, FABQ-W, and PCS. The ODQ and PIS were the dependent variables for these models. These analyses would provide information on the FDAQ in relation to previously established measures, as well as whether the assessment of the FAM should include general and specific measures.
Predictive validity was assessed by investigating whether baseline FDAQ scores contributed additional variance to 4-week outcomes for disability and physical impairment. In these models, the baseline scores for the ODQ and PIS first were entered into the model to predict the respective 4-week outcomes. In the second step of the models, the NRS for pain intensity, FABQ-PA, FABQ-W, PCS, and FDAQ were considered in a stepwise manner. These analyses provided information on whether the FDAQ could potentially be used as a screening tool to predict outcomes compared with the previously validated measures related to the FAM. Predictive validity was assessed further by determining whether 4-week changes in the FDAQ scores contributed additional variance to 4-week changes for disability and physical impairment. In these models, change scores for the NRS for pain intensity, FABQ-PA, FABQ-W, PCS, and FDAQ were considered as predictors in a stepwise manner for 4-week changes in scores for the ODQ and PIS (separate models). These analyses provided information on whether changes in the FDAQ scores were associated with changes in accepted outcome measures for LBP. 26, 27 Responsiveness was assessed by paired t test and calculation of effect size (Cohen d) for those participants who completed the 4-week followup. The percentage of participants from the reliability cohort who met the MDC criterion was calculated to provide a categorical estimate of responsiveness.
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Results
Descriptive statistics for baseline measures of the reliability and validity cohorts are reported in Table 1 . Ninety-two percent (46/50) of the participants in the reliability cohort completed the 48-hour assessment, with no differences in key variables for those who completed and those who did not complete the reliability follow-up. The validity cohort was followed for 4 weeks, with 85% (92/ 108) of the participants providing
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follow-up. For the validity cohort, baseline age, sex, disability, pain intensity, fear-avoidance beliefs, pain catastrophizing, and physical impairment scores were compared between those who completed and those who did not complete the 4-week assessments. None of the variables showed statistically significant (PϾ.05) differences for these comparisons.
Reliability
At baseline, Cronbach alpha was .91 (95% CIϭ87-.95) for the FDAQ, suggesting high levels of internal consistency among FDAQ items. The 48-hour test-retest reliability coefficient for the FDAQ was .90 (95% CIϭ.82-.94). Based on baseline data and these reliability data, the SEM was 6.6, resulting in an MDC of 12.9.
Construct Validity
The baseline factor analysis identified a 2-factor solution, with eigenvalues of 6.3 (62.8% variance) and 1.1 (10.8% variance), respectively. Factor loadings ranged from .59 to .92, with all 10 items loaded onto these 2 factors (Tab. 2). The factors created represented a loaded spine/ upright posture factor and a spinal motion/seated posture factor.
The 4-week factor analysis identified a 3-factor solution, with eigenvalues of 4.3 (49.3% variance), 1.4 (13.5% variance), and 1.1 (10.2% variance), respectively. Factor loadings ranged from .51 to .87, with all factors loaded onto these 3 factors (Tab. 2). The factors created were similar to those of the baseline solution by including loaded spine and spinal motion factors. At 4 weeks, a postural factor also was observed, as the seated and upright posture items were no longer split on the factor solution. The item assessing fear of performing back exercises was cross-loaded on the postural and spinal motion factors. This item remained in the FDAQ for the remaining analyses because of its potential for clinical utility.
Concurrent Validity
The correlation results for concurrent validity are summarized in Table  3 . At baseline and 4 weeks, the FDAQ scores were moderately correlated with scores on the FABQ-PA, FABQ-W, PCS, NRS for pain intensity, and PIS (Pearson rϭ.24 -.52, PϽ.05). There were stronger correlations for the ODQ at baseline and 4 weeks (Pearson r ϭ 0.70 and 0.49, PϽ 0.01).
The separate multiple regression models predicting ODQ scores accounted for 57% of the variance at baseline and for 51% of the variance at 4 weeks (Tab. 4). At baseline, the FDAQ was the strongest contributor to variance in ODQ scores (␤ϭ.52, PϽ.01), and the FABQ-W also contributed to the model (␤ϭ.20, Pϭ.01). At 4 weeks, the FDAQ contributed to disability (␤ϭ.24, Pϭ.01), but in this case, pain intensity was the strongest contributor to the model (␤ϭ.49, PϽ.01). 
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The separate multiple regression models predicting PIS scores accounted for 28% of the variance at baseline and for 21% of the variance at 4 weeks (Tab. 4 
Discussion
This study investigated the psychometric properties of the FDAQ, a novel self-report questionnaire for rating fearful activities. The FDAQ was used for activity selection in a clinical trial that studied physical therapy supplemented with graded exposure, 20 but it had not been subjected to detailed psychometric analyses. Collectively, the analyses presented in this article suggest that the FDAQ may be an appropriate measure to determine fear levels of specific activities in outpatient physical therapy settings.
Our analyses indicated that baseline FDAQ scores did not explain additional variance in disability and physical impairment outcomes. Therefore, it would be inappropriate to recommend routine use of the FDAQ as a general screening tool for all patients with LBP. Clinical implementation of the FDAQ may be appropriate after elevated pain-related fear is detected with a measure that has demonstrated predictive validity, such as the FABQ. Instead, our analyses indicated that the FDAQ had strong associations with current disability and weak associations with current impairment and that changes in FDAQ scores were predictive of changes in disability. The FDAQ was responsive to change, as approximately 55% of the participants met or exceeded the MDC of 12.9 during the 4 weeks of treatment. Collectively, these data indicate the FDAQ should be used as a focused measurement tool for determining activities to incorporate into graded exposure physical therapy treatment plans and as a way to monitor changes in patient fear levels.
The FDAQ had a clinically viable factor solution, indicating patients with acute or subacute LBP have a fear of loaded spine activities, postural components, and specific spinal motions. The FDAQ was significantly correlated with established measures, but shared only a maximum of 25% variance with the PCS, so construct redundancy with other FAM variables did not appear to be a concern. Stronger evidence for the FDAQ comes from multiple regression models for disability in which concurrent validity was demonstrated through unique contribution to variance in ODQ scores at baseline (with the FABQ-W) and at 4 weeks (with The ODQ levels reported in this study were comparable across the reliability and validity cohorts, but they corresponded with moderate disability overall. Therefore, these findings may not be applicable for patients with higher intake ODQ scores. We reported concurrent and predictive associations with the FDAQ and an established self-report of disability, the ODQ. 26,27 These associations are encouraging, but also could be related to both questionnaires being self-report, with items related to spine posture and loading of the spine. We found weaker associations with the FDAQ and our measure of physical impairment (PIS), and future study is necessary to determine whether the FDAQ also is related to physical impairment or other physical performance measures.
Another limitation is that we did not assess why patients were fearful of certain activities. The exact reasons for their fear were beyond the intended scope of this study. However, these reasons may be important to consider in the rehabilitation 
Conclusion
The FAM has received empirical support in the literature, but there are still lingering questions regarding its clinical application. One remaining issue is whether it is adequate to assess general beliefs consistent with the FAM, or whether it is necessary to assess fear of specific activities. This study suggests that the FDAQ is a potentially viable measure to determine fear of specific activities in physical therapy settings because it has sound psychometric properties, including a viable factor solution, adequate test-retest reliability, and responsiveness, contributing unique variance to self-report of disability in concurrent and predictive analyses. Future research is needed to confirm the factor solution of the FDAQ and to assess whether these findings are applicable to other samples of patients with LBP.
